4-Hydroxy-triazolam
CAS: 65686-11-5
Ref. 3D-QCA68611
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepin-4-ol, 8-chloro-6-(2-chlorophenyl)-1-methyl-
4-Hydroxy-triazolam is an analog of triazolam that has shown promising anticancer activity. It has been found to induce apoptosis in cancer cells and inhibit the growth of tumors. This compound is excreted primarily in urine and has been studied extensively as a potential inhibitor of kinases and elastase, both of which are involved in cancer progression. 4-Hydroxy-triazolam has also been investigated for its potential use as an anticancer drug in Chinese medicine. Although it shares some structural similarities with etomidate, a general anesthetic, it has distinct pharmacological properties that make it a promising candidate for further study as a cancer therapy.
Propiedades químicas
Consulta técnica sobre: 3D-QCA68611 4-Hydroxy-triazolam
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
